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All strains of Escherichia coli isolated from cases of hemorrhagic colitis and sent to the Centers for Disease
Control, Atlanta, Ga., over a 3-year period were assayed for toxicity in Vero cell cultures. Strains that
produced moderate or high levels of verotoxin were characterized by serotype, biotype, antimicrobial
resistance, plasmid profile, and adherence to HeLa cells. Over 200 isolates were typical 0157:H7 strains. Six
isolates were atypical 0157:H7 strains; two were resistant to antimicrobial agents; one was indole negative, two
were citrate positive, and one was urea positive. Six isolates were nonmotile 0157 strains. Ali of these isolates
were similar to typical 0157:H7 strains by plasmid profile and negative or slow sorbitol fermentation. Eleven
other verotoxigenic isolates did not possess the 0157 antigen, had a variety of plasmid profiles, and were
sorbitol positive. Two of the eleven were enteropathogenic serotypes (0111:NM and 026:H11), yet none were
adherent to HeLa cells. We conclude that verotoxigenic E. coli associated with hemorrhagic colitis includes
atypical 0157 strains and other serotypes. Hence, investigators should use current screening methods with
caution.
Since 1982, Escherichia coli 0157:H7 has been recognized
as the most important etiologic agent of hemorrhagic colitis,
which is characterized by severe abdominal pain and watery
stools, followed by frankly bloody diarrhea (14). This
serotype appeared to be unique among E. coli and the 0157
serogroup in its association with disease and in strain char-
acteristics, such as plasmid profile and biotype (20). Hem-
orrhagic colitis has also occurred as a prodrome to hemolytic
uremic syndrome (HUS) (17). Outbreaks and sporadic cases
of both diseases have occurred throughout the United States
and Canada (7, 13, 14, 17; W. R. Gransden, S. Damm, and
J. D. Anderson, Letter, Ann. Intern. Med. 103:160, 1985;
W. M. Johnson, H. Lior, and G. S. Bezanson, Letter,
Lancet i:76, 1983). Although E. coli 0157:H7 was isolated
from a frozen hamburger patty during the Michigan outbreak
of hemorrhagic colitis, no natural reservoir has been well
documented (20).
Although E. coli 0157:H7 strains do not produce tradi-
tional E. coli enterotoxins and are not enteroinvasive or
enteroadherent (20), they all produce at least one of a group
of antigenically variant toxins that are cytopathogenic to
Vero cell cultures (Johnson et al., Letter). The toxins are
collectively referred to as verotoxin (VT) and individually
are referred to as VT1, VT2, etc. (M. A. Karmali, M. Petric,
S. Louie, and R. Cheung, Letter, Lancet i:164-165, 1986;
S. M. Scotland, H. R. Smith, and B. Rowe, Letter, Lancet
ii:885-886, 1985). E. coli 0157:H7 toxins are also referred to
by some authors as Shiga-like toxins (SLT) because SLT-I
(or VT1) is neutralized by antibodies to Shigella dysenteriae
type 1 toxin (Shiga toxin) (12, 19; A. D. O'Brien, T. A.
Lively, T. W. Chang, and S. L. Gorbach, Letter, Lancet
ii:573, 1983). A role for this cytotoxin has been proposed in
the pathogenesis of HUS, and growing evidence shows that
VT-producing strains of E. coli, other than 0157:H7 strains,
are associated with HUS (M. A. Karmali, M. Petric, C. Lim,
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P. C. Fleming, and B. T. Steele, Letter, Lancet ii:1299-
1300, 1983). We believe that the same may be true for
hemorrhagic colitis.
To investigate this, we screened all E. coli isolates from
sporadic cases of hemorrhagic colitis over the past 3 years
and sent to the Centers for Disease Control, Atlanta, Ga.,
testing them for moderate or high levels of VT production.
Strains selected on this basis were characterized by
serotype, biotype, and antimicrobial susceptibility. Current
screening procedures are based on negative or slow fermen-
tation of sorbitol and the detection of H7 antigen (11); most
strains of E. coli, other than 0157:H7 strains, are thereby
excluded from further analysis.
MATERIALS AND METHODS
Bacterial strains. E. coli strains isolated from patients with
hemorrhagic colitis and sent to the Centers for Disease
Control during a 3-year period were screened for VT pro-
duction. Twenty-three toxigenic isolates were found to be
different from the typical E. coli 0157:H7 strains and were
included in this study of unusual VT-producing E. coli
associated with hemorrhagic colitis. Biochemical and sero-
logical identification of these strains was performed as
described previously (4, 6, 8). Antimicrobial susceptibility to
ampicillin, cephalothin, chloramphenicol, gentamicin,
kanamycin, naladixic acid, neomycin, nitrofurantoin,
sulfisoxazole, streptomycin, tetracycline, and trimethoprim-
sulfamethoxazole was determined by the disk diffusion
method (1).
VT and adherence assays. Strains to be assayed for VT
production were inoculated into Evans CAYE (2% Casamino
Acids, 0.15% yeast extract, 0.25% NaCl, 0.871% K2HPO4,
0.25% glucose, 0.1% trace salts solution [5% MgSO4, 0.5%
MnCl2, 0.5% FeCl3 6 H20], pH 8.5). The broth cultures
were incubated for 24 h at 37°C on a roller drum rotating at
20 rpm. Broth cultures were centrifuged at 3,500 x g for 20
min. The supernatants were removed and recentrifuged for 5
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TABLE 1. E. coli 0157:H7 strains with unusual biochemical reactions or resistance to multiple antimicrobial agents
Strain Origin Yr VT
V Antimicrobial Plasmid content Unusual biochemical
neutralizationa resistance (MDa) reactions
161-84 Ohio 1982 P None 60 Citrate (+)
1011-84 Maine 1984 P None 60, 2.1 Indole (-)
3230-85 Washington 1985 P None 60, 2.1 Citrate (+)
3124-85 Massachusetts 1985 + Tc Sm Su 60, 40, 2.1 None
A9167-1 Washington 1983 + Tc Sm Su 60, 2.1 None
3174-87 Texas 1987 - None 60, 30 Urea (+)
a Neutralization was determined by using a monoclonal antibody directed against Shiga-like toxin as described by Strockbine et al. (18). P, Partial
neutralization.
b Tc, Tetracycline; Sm, streptomycin; Su, sulfisoxazole.
min. The resulting supernatants were assayed in Vero cells
for the presence of cytotoxin as previously described (10). In
some cases, the cells were collected by centrifugation, lysed
by sonication, and assayed in Vero cells in the same manner
as the supernatants were (12).
Toxin neutralization was determined with a monoclonal
antibody to one VT1 (SLT-I). The antibody is described in
detail elsewhere (18) and was kindly provided by N. A.
Strockbine and A. D. O'Brien of the Uniformed Services
University of the Health Sciences, Bethesda, Md. Poly-
myxin B sulfate extracts of heart infusion agar-grown cul-
tures were diluted 1:10 in cell growth medium and antiserum
and incubated for 1 h at 37°C, and 0.1-ml extracts were
applied to HeLa cell monolayers in microtiter plates. After
overnight incubation, the wells were examined microscopi-
cally for cell death. The extent of neutralization was re-
corded as complete (VT1), partial (VT1 plus putative VT2),
or none (putative VT2). A specific antibody against VT2 was
not available.
Ail strains were assayed for adherence to HeLa cells as
described by Scaletsky et al. (15).
Plasmid analysis. Plasmid DNA was isolated from all
strains by the method of Birnboim and Doly (2). Plasmid
DNA preparations were electrophoresed through a vertical
agarose gel at 35 mA for 2 to 2.5 h. Gels were then stained
with ethidium bromide, examined under UV light, and
photographed. Plasmid sizes were estimated by comparison
to plasmids ofknown molecular weight included on each gel.
These control plasmids were Ri (62 megadaltons [MDa]),
RP4 (36 MDa), S-a (23 MDa), and pDK9 (140 and 105 MDa).
RESULTS
More than 200 VT-producing E. coli isolates from hemor-
rhagic colitis gave reactions typical of E. coli, except for
sorbitol fermentation. As described previously, E. coli
0157:H7 strains do not ferment sorbitol in less than 72 h (5,
20). Of these 200 E. coli 0157:H7 strains, none were
resistant to 12 antimicrobial agents when tested by the disk
diffusion method. Twenty-three isolates were unusual and
fell into three groups. The first group included six atypical E.
coli 0157:H7 strains. Two of these strains were resistant to
three antimicrobial agents, one was indole negative, one was
urea positive, and two were able to use citrate (Table 1). The
second group consisted of six nonmotile 0157 strains (i.e.,
they lack the flagellar H antigen) (Table 2). These two groups
of isolates were similar to typical 0157:H7 strains by plas-
mid profile (all possess a 60-MDa plasmid) and a negative or
slow sorbitol fermentation reaction.
The third group of VT-producing E. coli did not belong to
the 0157 serogroup, and only one isolate had the flagellar H7
antigen (050:H7) (Table 3). Two isolates were recognized
enteropathogenic E. coli (EPEC) serotypes, 0111:NM and
026:H11, and one isolate belonged to EPEC serogroup 0111
(serotype O111:H8). Although adherence to HeLa cell tissue
culture is a frequent characteristic of EPEC strains (15),
none of the isolates in this study adhered to HeLa cells. All
isolates in the third group contained at least one large
plasmid, ranging from 46 to 73 MDa, but the profiles were
not similar, except possibly for the two 0111 serogroup
strains. None of the plasmid profiles were similar to those of
the typical 0157:H7 strains.
Typical E. coli 0157:H7 strains produced VTs that were
wholly or partially capable of being neutralized with the
monoclonal antibody to VT1. One of the 0157:H7 strains,
one of the nonmotile 0157 strains, and three of the strains in
group 3 appeared to produce VT which was not neutralized
by the monoclonal antibody.
DISCUSSION
Strains of E. coli 0157:H7 isolated from outbreaks and
sporadic cases of hemorrhagic colitis and HUS have been
found to have similar plasmid profiles, to be susceptible to
antimicrobial agents, to be unable to ferment sorbitol within
48 h, and to produce moderate to high levels of VT (12, 20;
Johnson et al., Letter). None of the E. coli 0157 strains with
other H antigens, taken from the Centers for Disease Control
culture collection, were isolated from persons with hemor-
rhagic colitis; they had diverse plasmid profiles, were able to
ferment sorbitol rapidly, and did not produce detectable
levels of VT. Until recently, 0157:H7 strains have been
considered to be a single clone which might be the only
cause of hemorrhagic colitis. Investigators have used screen-
ing procedures based on H7 immobilization and sorbitol
fermentation which would ignore other E. coli (5, 11).
By using a screening procedure for toxin production, we
have identified several atypical 0157:H7 strains and
nonmotile 0157 serogroup strains during this 3-year study.
TABLE 2. Nonmotile E. coli 0157 strains isolated from
patients with hemorrhagic colitis
VT Atioi Plasmid
Strain Origin Yr neutrali- Antimcrobial content
zationa' resistance (MDa)
3123-85 North Dakota 1985 + None 60, 2.1
3199-85 Massachusetts 1985 - None 60, 40
3205-85 Michigan 1985 P None 60, 2.1
3344-85 Maryland 1985 P None 60, 40
3444-85 Massachusetts 1985 P None 60, 2.1
3460-85 Massachusetts 1985 P None 60, 2.1
a Neutralization was determined by using a monoclonal antibody directed
against Shiga-like toxin as described by Strockbine et al. (18). P. Partial
neutralization.
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TABLE 3. Serotypes (other than 0157:H7 or nonmotile 0157) of E. coli isolated from patients with hemorrhagic colitis
Strain Origin Yr Serotype VT Adherence Antimicrobial Plasmid content (MDa)
75-83 ~~~~~~~~~~~~~~neutralizationa Aheneresistanceb75-83 South Dakota 1982 0145:NM + - None 67
A9619-C2 Michigan 1983 045:H2 + - Cm Tc Na Ap Cb 60, 26, 15.3, 9.1, 4.9
Km Sm Su
3007-85 Nebraska 1985 0111:NM P - None 50, 12.3, 8.6
3143-85b United Kingdom 1985 05:NM + - Sm Su 54, 26, 7.5, 3.7, 3.2, 2.6
3288-85 California 1985 Ound:NM - - None 46
3377-85 Georgia 1983 04:NM P - Tc Sm 73, 46, 29, 22.5, 14.5, 5.2
3030A-86 Idaho 1986 0111:H8 P - None 50, 14.5, 12.3, 8.6
3047-86 Australia 1986 026:H11 + - None 54, 9.2, 8.6
3056-86 Maryland 1986 050:H7 - - None 73
3153B-86 North Carolina 1986 0125:NM + - None 54, 7.5
3056-85 Oklahoma 1985 0121:H19 - - None 54
a Neutralization was determined by using a monoclonal antibody directed against Shiga-like toxin as described by Strockbine et al. (18). P, Partial
neutralization.
b Sm, Streptomycin; Su, sulfisoxazole; Cm, chloramphenicol; Tc, tetracycline; Na, nalidixic acid; Ap, ampicillin; Cb, carbenicillin; Km, kanamycin.
Except for single biochemical reactions, antimicrobial resist-
ance, and the lack ofH7 antigen expression, these organisms
are indistinguishable from the H7 clone; i.e., they have
similar plasmid profiles, are slow in fermenting sorbitol,
produce VT, and have been isolated from persons with
hemorrhagic colitis. The nonmotile strains would not have
been detected by one of the currently available screening
procedures (5). Similarly, initial biochemical screening pro-
cedures would not usually recognize indole-negative, citrate-
positive, or urea-positive bacterial strains as E. coli and
might eliminate those from further study. Apparently no
single plasmid is associated with any atypical characteristic
or antibiotic resistance in these strains, but more detailed
genetic studies will be necessary to address this.
The VT-producing serotypes, other than 0157:H7 or
0157:NM, appear to constitute a diverse group (Table 3) and
do not share other H7 clone characteristics. It is not surpris-
ing to find E. coli strains, other than 0157:H7 strains, pro-
ducing toxins that are generally bacteriophage mediated (19).
In fact, at least two VT-producing phage have been identified
within 0157:H7 (19), and at least two antigenically distinct
VTs have been detected within 0157:H7 strains (18; Scot-
land et al., Letter). The monoclonal antibody used in this
study neutralizes Shiga toxin and antigenically similar Shiga-
like toxin (SLT-I or VT1). It appears that the 0, H, and toxin
antigen diversity seen in HUS E. coli isolates (9) can also
occur in hemorrhagic colitis E. coli isolates.
Only two of the serotypes in Table 3 have been recognized
as enteric pathogens in the past. Serotypes 0111:NM and
026:H11 are both classic EPEC strains and as early as 1977,
were reported to produce VT (10). When investigators have
selected 0111 and 026 strains from culture collections,
however, not all have produced detectable quantities of VT;
therefore, this quality does not seem to be a universal
characteristic of these E. coli serogroups (3, 16).
Production of VT by these unusual E. coli isolated from
hemorrhagic colitis and HUS patients does not prove that
these strains cause disease. However, the production of
detectable amounts of VT in culture supernatants does seem
to be at least a marker for E. coli strains associated with the
illnesses, since moderate to high VT levels are rarely pro-
duced by E. coli associated with other types of diarrhea or
from people who are not ill (12). Preliminary data also show
that the VT-producing E. coli in Table 3 can cause a
syndrome similar to that produced by E. coli 0157:H7 in the
gnotobiotic piglet; this syndrome is distinguishable from the
one reported for EPEC infections (S. Tzipori, I. K. Wach-
smuth, J. Smithers, and C. Jackson, submitted for publica-
tion). These organisms may well constitute a new group of
pathogenic E. coli and should be useful in studies of patho-
genesis.
Our findings also suggest that investigators using the
various sorbitol and H7 screening media (5, 11) should use
caution in interpreting or generalizing from their data. Pro-
spective studies using VT screening, as well as current
methods, are needed to determine the frequency with which
VT-producing E. coli strains, other than 0157:H7 strains,
are associated with disease.
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